Clinical trial

Personalizing Immune Checkpoint Inhibitor Therapy

NCT03409341

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2019-02-01

PhaseN/A

Study timeline

Study start (actual)2019-02-01Date precision: day

Registry last updated2020-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancer Stage IVunresolved

Interventions

Blood and tumor tissue analysis, Clinical response.OTHER

Sponsors & collaborators

Holy Cross Hospital, Marylandlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03409341 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.